FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086476589> ?p ?o ?g. }

• W2086476589 endingPage "414" @default.
• W2086476589 startingPage "395" @default.
• W2086476589 abstract "Syntheses and biological activities of imidazo-, pyrimido- and diazepino[2,1-f]purinediones containing N-alkyl substituents (with straight, branched or unsaturated chains) are described. Tricyclic derivatives were synthesized by the cyclization of 8-bromo-substituted 7-(2-bromoethyl)-, 7-(3-chloropropyl)- or 7-(4-bromobutyl)-theophylline with primary amines under various conditions. Compound 22 with an ethenyl substituent was synthesized by dehydrohalogenation of 9-(2-bromoethyl)-1,3-dimethyltetrahydropyrimido[2,1-f]purinedione. The obtained derivatives (5–35) were initially evaluated for their affinity at rat A1 and A2A adenosine receptors (AR), showing moderate affinity for both adenosine receptor subtypes. The best ligands were diazepinopurinedione 28 (K i = 0.28 μM) with fivefold A2A selectivity and the non-selective A1/A2A AR ligand pyrimidopurinedione 35 (K i A1 = 0.28 μM and K i A2A = 0.30 μM). The compounds were also evaluated for their affinity at human A1, A2A, A2B and A3 ARs. All of the obtained compounds were docked to the A2A AR X-ray structure in complex with the xanthine-based, potent adenosine receptor antagonist—XAC. The likely interactions of imidazo-, pyrimido- and diazepino[2,1-f]purinediones with the residues forming the A2A binding pocket were discussed. Furthermore, the new compounds were tested in vivo as anticonvulsants in maximal electroshock, subcutaneous pentylenetetrazole (ScMet) and TOX tests in mice (i.p.). Pyrimidopurinediones showed anticonvulsant activity mainly in the ScMet test. The best derivative was compound 11, showing 100 % protection at a dose of 100 mg/kg without symptoms of neurotoxicity. Compounds 6, 7, 8 and 14 with short substituents showed neurotoxicity and caused death. In rat tests (p.o.), 9 was characterized by a high protection index (>13.3). AR affinity did not apparently correlate with the antiepileptic potency of the compounds." @default.
• W2086476589 created "2016-06-24" @default.
• W2086476589 creator A5017915434 @default.
• W2086476589 creator A5023892948 @default.
• W2086476589 creator A5027962273 @default.
• W2086476589 creator A5052361178 @default.
• W2086476589 creator A5053955707 @default.
• W2086476589 creator A5054112103 @default.
• W2086476589 creator A5061946128 @default.
• W2086476589 creator A5064011310 @default.
• W2086476589 creator A5067048725 @default.
• W2086476589 creator A5077842508 @default.
• W2086476589 date "2013-04-02" @default.
• W2086476589 modified "2023-10-07" @default.
• W2086476589 title "Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones" @default.
• W2086476589 cites W1969444624 @default.
• W2086476589 cites W1970166961 @default.
• W2086476589 cites W1971024460 @default.
• W2086476589 cites W1975740938 @default.
• W2086476589 cites W1982263546 @default.
• W2086476589 cites W1988476821 @default.
• W2086476589 cites W1992958260 @default.
• W2086476589 cites W1994080331 @default.
• W2086476589 cites W1999820883 @default.
• W2086476589 cites W2003366915 @default.
• W2086476589 cites W2005077841 @default.
• W2086476589 cites W2005179275 @default.
• W2086476589 cites W2005456321 @default.
• W2086476589 cites W2008871586 @default.
• W2086476589 cites W2011059955 @default.
• W2086476589 cites W2023608091 @default.
• W2086476589 cites W2024044599 @default.
• W2086476589 cites W2028652800 @default.
• W2086476589 cites W2044787463 @default.
• W2086476589 cites W2048306700 @default.
• W2086476589 cites W2050083092 @default.
• W2086476589 cites W2050366220 @default.
• W2086476589 cites W2059087032 @default.
• W2086476589 cites W2064356380 @default.
• W2086476589 cites W2065708359 @default.
• W2086476589 cites W2068613384 @default.
• W2086476589 cites W2081184584 @default.
• W2086476589 cites W2087440184 @default.
• W2086476589 cites W2088526655 @default.
• W2086476589 cites W2089232549 @default.
• W2086476589 cites W2092222724 @default.
• W2086476589 cites W2093777829 @default.
• W2086476589 cites W2093884807 @default.
• W2086476589 cites W2096692295 @default.
• W2086476589 cites W2101848275 @default.
• W2086476589 cites W2106532502 @default.
• W2086476589 cites W2113518144 @default.
• W2086476589 cites W2121170525 @default.
• W2086476589 cites W2121975625 @default.
• W2086476589 cites W2135732482 @default.
• W2086476589 cites W2142322475 @default.
• W2086476589 cites W2155633484 @default.
• W2086476589 cites W2168634451 @default.
• W2086476589 cites W2313722604 @default.
• W2086476589 cites W2322920868 @default.
• W2086476589 cites W2323471917 @default.
• W2086476589 cites W3147665502 @default.
• W2086476589 doi "https://doi.org/10.1007/s11302-013-9358-3" @default.
• W2086476589 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3757144" @default.
• W2086476589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23543220" @default.
• W2086476589 hasPublicationYear "2013" @default.
• W2086476589 type Work @default.
• W2086476589 sameAs 2086476589 @default.
• W2086476589 citedByCount "15" @default.
• W2086476589 countsByYear W20864765892014 @default.
• W2086476589 countsByYear W20864765892015 @default.
• W2086476589 countsByYear W20864765892016 @default.
• W2086476589 countsByYear W20864765892019 @default.
• W2086476589 countsByYear W20864765892020 @default.
• W2086476589 countsByYear W20864765892021 @default.
• W2086476589 countsByYear W20864765892022 @default.
• W2086476589 countsByYear W20864765892023 @default.
• W2086476589 crossrefType "journal-article" @default.
• W2086476589 hasAuthorship W2086476589A5017915434 @default.
• W2086476589 hasAuthorship W2086476589A5023892948 @default.
• W2086476589 hasAuthorship W2086476589A5027962273 @default.
• W2086476589 hasAuthorship W2086476589A5052361178 @default.
• W2086476589 hasAuthorship W2086476589A5053955707 @default.
• W2086476589 hasAuthorship W2086476589A5054112103 @default.
• W2086476589 hasAuthorship W2086476589A5061946128 @default.
• W2086476589 hasAuthorship W2086476589A5064011310 @default.
• W2086476589 hasAuthorship W2086476589A5067048725 @default.
• W2086476589 hasAuthorship W2086476589A5077842508 @default.
• W2086476589 hasBestOaLocation W20864765891 @default.
• W2086476589 hasConcept C116073593 @default.
• W2086476589 hasConcept C116569031 @default.
• W2086476589 hasConcept C170493617 @default.
• W2086476589 hasConcept C181199279 @default.
• W2086476589 hasConcept C185592680 @default.
• W2086476589 hasConcept C202751555 @default.
• W2086476589 hasConcept C2776885963 @default.
• W2086476589 hasConcept C2776991684 @default.
• W2086476589 hasConcept C2778095195 @default.

• next